Edition:
United Kingdom

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

38.55USD
12 Dec 2017
Change (% chg)

$0.84 (+2.23%)
Prev Close
$37.71
Open
$37.39
Day's High
$38.84
Day's Low
$37.39
Volume
76,224
Avg. Vol
27,700
52-wk High
$44.38
52-wk Low
$13.01

Select another date:

Tue, Nov 14 2017

BRIEF-Urogen Pharma Q3 loss per share $0.02

* Urogen Pharma reports third quarter 2017 financial results and recent corporate developments

BRIEF-Menora Mivtachim reports 5.38 pct passive stake in UroGen Pharma ‍​

* Menora Mivtachim Holdings Ltd reports 5.38 percent passive stake in UroGen Pharma Ltd as of Nov 1 - SEC filing ‍​ Source: (http://bit.ly/2hdmj4k) Further company coverage:

BRIEF-Urogen Pharma receives FDA fast track designation for Mitogel

* Urogen Pharma receives FDA fast track designation for Mitogel for the treatment of upper tract urothelial carcinoma (UTUC)

BRIEF-UroGen Pharma Q2 loss per share $0.70

* UroGen Pharma reports second quarter 2017 financial results and recent corporate developments

BRIEF-Jay Moorin reports a 11.5 pct passive stake in Urogen Pharma

* Jay Moorin reports a 11.5 percent passive stake in Urogen Pharma Ltd as of May 9, 2017 - SEC filing Source text for Eikon: (http://bit.ly/2ufDxWd) Further company coverage:

BRIEF-Allergan submits investigational NDA for rtgel in combination with botox

* Investigational new drug application for rtgel™ in combination with botox® for the treatment of overactive bladder submitted to FDA by Allergan

Select another date: